Skip to content

HEIST-FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HEIST-FARMA

BE 0470.855.024
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€184,185
2024 · €134,218+€49,967
Equity
€334,887
2024 · €305,423+€29,464
Cash
€232,676
2024 · €202,079+€30,597
Balance sheet total
€610,567
2024 · €526,164+€84,403

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€34,594

    up €34,594 (+19.6%), from €176,479 to €211,074

  • Cash +€30,597

    up €30,597 (+15.1%), from €202,079 to €232,676

    mainly Net result for the year (+€184,185) and Tax, wage and social debts (+€24,266)

  • Receivables within one year +€17,150

    up €17,150 (+15.0%), from €114,153 to €131,303

    of which Trade receivables: +€18,021

Equity and liabilities
  • Profit (loss) carried forward +€84,185

    up €84,185 (+54.4%), from €154,639 to €238,824

  • Reserves -€54,721

    down €54,721 (-41.8%), from €130,784 to €76,063

    of which Distributable reserves: -€54,721

  • Tax, wage and social debts +€24,266

    up €24,266 (+164%), from €14,760 to €39,026

    of which Taxes: +€20,422

  • Trade debts +€21,887

    up €21,887 (+31.2%), from €70,170 to €92,058

  • Other debts +€8,775

    up €8,775 (+6.5%), from €135,366 to €144,141

Income statement
  • Gross operating margin +€98,079

    up €98,079 (+34.0%), from €288,331 to €386,411

  • Staff costs +€29,616

    up €29,616 (+25.5%), from €116,218 to €145,834

  • Taxes +€18,627

    up €18,627 (+149%), from €12,489 to €31,116

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €134,218
Gross operating margin +€98,079
Staff costs -€29,616
Depreciation +€2,690
Other operating charges -€396
Financial income -€651
Financial charges -€1,512
Taxes -€18,627
Result 2025 €184,185
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€191,820
Investment -€6,502
Financing -€154,721
Cash 2024 €202,079
Net result for the year +€184,185
Depreciation +€2,134
Stocks and contracts -€34,594
Receivables within one year -€17,150
Deferred charges and accrued income +€2,307
Trade debts +€21,887
Tax, wage and social debts +€24,266
Other debts +€8,775
Accrued charges and deferred income +€10
Investment in fixed assets (net) -€6,502
Contributions, distributions and other -€154,721
Cash 2025 €232,676
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €526,164 €610,567 +€84,403 +16.0%
Fixed assets 21/28 €15,004 €19,373 +€4,368 +29.1%
Intangible fixed assets 21 €0 €0 =
Tangible fixed assets 22/27 €10,004 €14,373 +€4,368 +43.7%
Plant, machinery and equipment 23 €6,067 €6,979 +€912 +15.0%
Furniture and vehicles 24 €545 €4,924 +€4,379 +804%
Other tangible fixed assets 26 €3,392 €2,469 -€923 -27.2%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €511,160 €591,194 +€80,035 +15.7%
Stocks and contracts in progress 3 €176,479 €211,074 +€34,594 +19.6%
Stocks 30/36 €176,479 €211,074 +€34,594 +19.6%
Amounts receivable within one year 40/41 €114,153 €131,303 +€17,150 +15.0%
Trade receivables 40 €111,556 €129,577 +€18,021 +16.2%
Other amounts receivable 41 €2,597 €1,726 -€871 -33.5%
Cash at bank and in hand 54/58 €202,079 €232,676 +€30,597 +15.1%
Deferred charges and accrued income 490/1 €18,448 €16,141 -€2,307 -12.5%
Total equity and liabilities 10/49 €526,164 €610,567 +€84,403 +16.0%
Equity 10/15 €305,423 €334,887 +€29,464 +9.6%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €130,784 €76,063 -€54,721 -41.8%
Tax-exempt reserves 132 €49,863 €49,863 = 0.0%
Distributable reserves 133 €80,921 €26,200 -€54,721 -67.6%
Profit (loss) carried forward 14 €154,639 €238,824 +€84,185 +54.4%
Amounts payable 17/49 €220,741 €275,680 +€54,939 +24.9%
Amounts payable within one year 42/48 €220,296 €275,225 +€54,929 +24.9%
Trade debts 44 €70,170 €92,058 +€21,887 +31.2%
Suppliers 440/4 €70,170 €92,058 +€21,887 +31.2%
Taxes, remuneration and social security 45 €14,760 €39,026 +€24,266 +164%
Taxes 450/3 €816 €21,238 +€20,422 +2,502%
Remuneration and social security 454/9 €13,943 €17,788 +€3,844 +27.6%
Other amounts payable 47/48 €135,366 €144,141 +€8,775 +6.5%
Accrued charges and deferred income 492/3 €445 €456 +€10 +2.3%
Remuneration, social security and pensions 62 €116,218 €145,834 +€29,616 +25.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,824 €2,134 -€2,690 -55.8%
Other operating charges 640/8 €1,198 €1,594 +€396 +33.1%
Gross operating margin 9900 €288,331 €386,411 +€98,079 +34.0%
Operating profit (loss) 9901 €166,092 €236,849 +€70,757 +42.6%
Financial income 75/76B €3,130 €2,479 -€651 -20.8%
Recurring financial income 75 €3,130 €2,479 -€651 -20.8%
Financial charges 65/66B €22,515 €24,027 +€1,512 +6.7%
Recurring financial charges 65 €22,515 €24,027 +€1,512 +6.7%
Profit (loss) for the period before taxes 9903 €146,707 €215,301 +€68,594 +46.8%
Income taxes 67/77 €12,489 €31,116 +€18,627 +149%
Profit (loss) for the period 9904 €134,218 €184,185 +€49,967 +37.2%
Profit (loss) for the period to be appropriated 9905 €134,218 €184,185 +€49,967 +37.2%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.